2014
DOI: 10.1016/j.msec.2014.08.059
|View full text |Cite
|
Sign up to set email alerts
|

Gentamicin release from biodegradable poly-l-lactide based composites for novel intramedullary nails

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2016
2016
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(23 citation statements)
references
References 27 publications
0
23
0
Order By: Relevance
“…The improvement in crystallization rate and nucleation density of PLLA was observed, in which RCF fibers acted as a nucleation agent. Anna Morawska-Chochol et al (2014) [119] reported the development of novel, multiphase and multifunctional degradable intramedullary nails. Three different composites containing PLLA as matrix and carbon [120] followed polymer coagulation and salt-particle leaching method to fabricate porous PU composites reinforced with different concentration of bioglass.…”
Section: Pllamentioning
confidence: 99%
“…The improvement in crystallization rate and nucleation density of PLLA was observed, in which RCF fibers acted as a nucleation agent. Anna Morawska-Chochol et al (2014) [119] reported the development of novel, multiphase and multifunctional degradable intramedullary nails. Three different composites containing PLLA as matrix and carbon [120] followed polymer coagulation and salt-particle leaching method to fabricate porous PU composites reinforced with different concentration of bioglass.…”
Section: Pllamentioning
confidence: 99%
“…[108][109][110][111] Recent studies are already starting to show this tendency. [112][113][114][115] A promising product already in the market is the Expert Tibia Nail PROtect option, which offers protection from bacterial colonization through a local antibiotic prophylaxis coating while maintaining the same technique and instrumentation as the uncoated nails. However, bioactive coatings are still associated with challenges, such as penetration and diffusion barriers for antibiotic dissemination (e.g., tissue change due to inflammation or necrosis), the fact that even high doses of active substances may not always ensure adequate levels of effect, the high cost of growth factors, and the potential for ectopic bone formation caused by growth factures (not to mention the challenging regulatory pathway associated).…”
Section: Future Insightsmentioning
confidence: 99%
“…To date, a number of magnesium based drug release orthopedic implant material have been reported, which focus on antibiotics, such as gentamicin [15], gentamicin sulfate [16], or antimicrobial peptide [17]. However, few research of anti-inflammatory drugs such as ibuprofen was reported.…”
Section: Introductionmentioning
confidence: 99%
“…However, few research of anti-inflammatory drugs such as ibuprofen was reported. At the same time, burst release phenomenon in initial stage is still a problem [15][16][17][18][19].…”
Section: Introductionmentioning
confidence: 99%